These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 4925338)
1. [1st results of the clinical examination of Adriamycin]. Obrecht P; Westerhausen M; Simon A Dtsch Med Wochenschr; 1971 Feb; 96(9):369-76. PubMed ID: 4925338 [No Abstract] [Full Text] [Related]
2. Phase II evaluation of aclarubicin in advanced breast cancer: a Southeastern Cancer Study Group trial. Gockerman JP; Raney M; Logan T Cancer Treat Rep; 1985 Sep; 69(9):1029-30. PubMed ID: 3861247 [No Abstract] [Full Text] [Related]
3. [A phase I trial of 4'-epiadriamycin]. Ogawa M; Ikeda K; Inagaki J; Horikoshi N; Inoue K; Nakada K; Usui N; Okada Y; Adachi K; Tada A Gan To Kagaku Ryoho; 1984 Apr; 11(4):926-9. PubMed ID: 6586111 [TBL] [Abstract][Full Text] [Related]
4. Phase II evaluation of piperazinedione in metastatic breast carcinoma. Palmer RL; Samal BA; Vaughn CB; Tranum BL Cancer Treat Rep; 1977 Dec; 61(9):1711-2. PubMed ID: 340035 [No Abstract] [Full Text] [Related]
5. Phase I and preliminary phase II evaluation of adriamycin (NSC 123127). Bonadonna G; Monfardini S; De Lena M; Fossati-Bellani F; Beretta G Cancer Res; 1970 Oct; 30(10):2572-82. PubMed ID: 5474180 [No Abstract] [Full Text] [Related]
6. Phase II trial of acivicin in advanced breast carcinoma: a Cancer and Leukemia Group B Study. Booth BW; Korzun AH; Weiss RB; Ellison RR; Budman D; Khojasteh A; Wood W Cancer Treat Rep; 1986 Oct; 70(10):1247-8. PubMed ID: 3530455 [No Abstract] [Full Text] [Related]
7. [Phase I clinical study of MX2 (KRN 8602)]. Majima H Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):359-64. PubMed ID: 2310202 [TBL] [Abstract][Full Text] [Related]
8. American symposium looks at new antineoplastic drug. Korcok M Can Med Assoc J; 1985 Jul; 133(1):66-7. PubMed ID: 3891062 [No Abstract] [Full Text] [Related]
9. [1st experiences with Adriamycin, a new cytotoxic antibiotic, in combination chemotherapy of malignant tumors]. Jungi WF; Mayr AC; Smith P; Nagel GA; Senn HJ Schweiz Med Wochenschr; 1972 Aug; 102(34):1213-21. PubMed ID: 4506295 [No Abstract] [Full Text] [Related]
10. [Use of pharmorubicin in cancer of the breast]. Ass NIa; Borisov VI Sov Med; 1986; (10):36-9. PubMed ID: 3544240 [No Abstract] [Full Text] [Related]
11. Azotomycin (NSC-56654)--clinical brochure. Carter SK Cancer Chemother Rep 3; 1968 Dec; 1(1):207-17. PubMed ID: 4917775 [No Abstract] [Full Text] [Related]
12. [New 2004 guidelines of the Breast Organ Committee of AGO]. Krankenpfl J; 2004; 42(3-4):81. PubMed ID: 15311888 [No Abstract] [Full Text] [Related]
13. Phase II clinical trial of acivicin in advanced breast cancer: an Eastern Cooperative Oncology Group Study. Willson JK; Knuiman MW; Skeel RT; Wolter JM; Pandya KJ; Falkson G; Chang YC Cancer Treat Rep; 1986 Oct; 70(10):1237-8. PubMed ID: 3530452 [No Abstract] [Full Text] [Related]
14. [Results of clinical study of the antineoplastic antibiotic rubomycin]. Akop'iants SS Antibiotiki; 1968 Sep; 13(9):846-50. PubMed ID: 4884477 [No Abstract] [Full Text] [Related]
15. [Rubomycin in the therapy of acute leukemias]. Khvatova NV Antibiotiki; 1970 Dec; 15(12):1108-11. PubMed ID: 5278101 [No Abstract] [Full Text] [Related]
16. Phase II evaluation of pyrazofurin in patients with carcinoma of the lung. Gralla RJ; Currie VE; Wittes RE; Golbey RB; Young CW Cancer Treat Rep; 1978 Mar; 62(3):451-2. PubMed ID: 348315 [No Abstract] [Full Text] [Related]
17. Clinical studies of aclacinomycin A (ACM). Majima H; Ohta K Biomed Pharmacother; 1987; 41(5):233-7. PubMed ID: 3311189 [TBL] [Abstract][Full Text] [Related]
18. A clinical trial of mithramycin in the treatment of advanced malignant disease. Baum M Br J Cancer; 1968 Jun; 22(2):176-83. PubMed ID: 4873186 [No Abstract] [Full Text] [Related]
19. Clinical evaluation of adriamycin, a new antitumour antibiotic. Bonadonna G; Monfardini S; De Lena M; Fossati-Bellani F Br Med J; 1969 Aug; 3(5669):503-6. PubMed ID: 5257148 [TBL] [Abstract][Full Text] [Related]
20. Paclitaxel (Taxol) efficacy in patients with advanced breast cancer resistant to anthracyclines. Gianni L; Capri G; Munzone E; Straneo M Semin Oncol; 1994 Oct; 21(5 Suppl 8):29-33. PubMed ID: 7939759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]